CIK 0001464521 · <br>Emerging growth company
Heartflow, Inc.
Sign in to watch- Ticker
- HTFL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260506743
- Phone
- 650-241-1221
- Business address
- 135 MAIN STREET, SUITE 1000, SAN FRANCISCO, CA, 94105
- Former names
- Cardiovascular Simulation, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,602,722
- in 13 filings, $16.6M under 10b5-1 plans
Net −$16,602,722. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-17 | BARABE TIMOTHY C Director | Option exercise · Stock Option | −5,000 | 18,710 | ||
| 2026-07-15 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +9,219 | $19.00 | $175K | 97,950 |
| 2026-07-15 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −9,219 | $25.72 | $237K | 88,731 |
| 2026-07-15 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Options 10b5-1 | −9,219 | 92,191 | ||
| 2026-07-10 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −22,562 | $27.75 | $626K | 435,373 |
| 2026-07-08 | WELDON WILLIAM C Director | Option exercise | +17,123 | $8.33 | $143K | 209,685 |
| 2026-07-08 | WELDON WILLIAM C Director | Option exercise | +17,123 | $8.33 | $143K | 226,808 |
| 2026-07-08 | WELDON WILLIAM C Director | Option exercise | +17,123 | $8.33 | $143K | 243,931 |
| 2026-07-08 | WELDON WILLIAM C Director | Option exercise · Stock Option | −17,123 | 0 | ||
| 2026-07-08 | WELDON WILLIAM C Director | Option exercise · Stock Option | −17,123 | 0 | ||
| 2026-07-08 | WELDON WILLIAM C Director | Option exercise · Stock Option | −17,123 | 0 | ||
| 2026-06-24 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −38,900 | $35.00 | $1.4M | 457,935 |
| 2026-06-16 | WELDON WILLIAM C Director | Grant or award · Stock Option | +16,075 | $32.05 | $515K | 16,075 |
| 2026-06-16 | BARABE TIMOTHY C Director | Grant or award · Stock Option | +16,075 | $32.05 | $515K | 16,075 |
| 2026-06-16 | Cullivan Julie A Director | Grant or award · Stock Option | +16,075 | $32.05 | $515K | 16,075 |
| 2026-06-16 | Lightcap Jeffrey C Director | Grant or award · Stock Option | +16,075 | $32.05 | $515K | 16,075 |
| 2026-06-16 | Riley Wayne Joseph Director | Grant or award · Stock Option | +16,075 | $32.05 | $515K | 16,075 |
| 2026-06-16 | Tansey Casey M Director | Grant or award · Stock Option | +16,075 | $32.05 | $515K | 16,075 |
| 2026-06-15 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +10,000 | $2.22 | $22K | 88,731 |
| 2026-06-15 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −10,000 | 71,633 |
Page 4 of 12 · 224 trades